Viewing Study NCT04951050


Ignite Creation Date: 2025-12-24 @ 5:06 PM
Ignite Modification Date: 2025-12-27 @ 2:33 AM
Study NCT ID: NCT04951050
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-11-09
First Post: 2021-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment
Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module